Find comprehensive information on metastatic ovarian cancer, including clinical documentation, medical coding (ICD-10, ICD-O), staging, treatment options, and healthcare resources. Learn about symptoms, diagnosis, prognosis, and the latest research related to advanced ovarian cancer. This resource provides essential information for healthcare professionals, patients, and caregivers seeking guidance on managing and understanding metastatic ovarian cancer. Explore topics such as palliative care, clinical trials, and support groups for individuals affected by ovarian cancer metastasis.
Also known as
Malignant neoplasm of ovary
Covers primary and secondary malignant ovarian tumors.
Secondary malignant neoplasm of peritoneum
Includes ovarian cancer that has spread to the peritoneum.
Secondary malignant neoplasm of other specified sites
Use for ovarian cancer metastasized to locations not covered elsewhere.
Malignant neoplasm without specification of site
For disseminated ovarian cancer where primary site is unknown.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the ovarian cancer primary?
When to use each related code
| Description |
|---|
| Metastatic ovarian cancer |
| Primary peritoneal cancer |
| Fallopian tube cancer |
Incorrect coding of laterality (right, left, bilateral) for metastatic ovarian cancer can impact staging and treatment data.
Insufficient documentation confirming the ovary as the primary site for metastatic disease leads to coding errors and claim denials.
Lack of specific documentation of metastatic sites (e.g., peritoneum, liver) affects accurate coding and reimbursement.
Patient presents with signs and symptoms suggestive of metastatic ovarian cancer. Presenting complaints include abdominal distension, pelvic pain, bloating, early satiety, and urinary frequency or urgency. Physical examination reveals abdominal tenderness, palpable mass, ascites, or pleural effusion. Patient reports a family history of ovarian cancer, breast cancer, or other related malignancies. CA-125 levels are elevated. Imaging studies, including pelvic ultrasound, CT scan of the abdomen and pelvis, and chest X-ray, demonstrate findings consistent with metastatic ovarian cancer. Biopsy confirms the diagnosis of high-grade serous ovarian carcinoma with metastasis to the peritoneum, omentum, and or other distant sites. The patient's performance status is assessed using the Eastern Cooperative Oncology Group (ECOG) scale. Differential diagnosis includes benign ovarian masses, other gynecological malignancies, and gastrointestinal disorders. Treatment plan includes surgical debulking, cytoreductive surgery, chemotherapy with platinum-based agents and taxanes, and or targeted therapy depending on molecular profiling and disease stage. Patient education regarding prognosis, treatment options, and potential side effects was provided. Referral to oncology, genetic counseling, and palliative care is initiated. Follow-up appointments are scheduled for monitoring of treatment response, disease progression, and management of complications. ICD-10 code C56.9 Ovarian cancer, unspecified, is documented.